Observational study / 2018
Elite chess grandmasters showed a survival advantage over the general population similar to that of Olympic medallists.
This study compared survival and life expectancy of 1,208 International Chess Grandmasters (GMs) and 15,157 Olympic medallists (OMs) across 28 countries with the general population. Life expectancy of GMs at age 30 was 53.6 years (95% CI: 47.7-58.5), significantly higher than 45.9 years in the general population. GMs in North America (HR: 0.51, 95% CI: 0.29-0.88) and Western Europe (HR: 0.53, 95% CI: 0.34-0.83) had longer lifespans compared to Eastern Europe. At 30 years, relative survival did not differ significantly between GMs (1.14, 95% CI: 1.08-1.20) and OMs (1.09, 95% CI: 1.07-1.11), with both groups showing an advantage over the general population.
Shows an association, not proof of cause and effect.
- Study type
- Retrospective cohort study
- Who was studied
- 1,208 International Chess Grandmasters and 15,157 Olympic medallists from 28 countries
- What was measured
- Survival rates, life expectancy, and relative survival compared to the general population
THE PAPER
Longevity of outstanding sporting achievers: Mind versus muscle.
Tran-Duy A, Smerdon DC, Clarke PM. PLoS One, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.